Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

  1.1.1 Why This Market Is Gaining Strategic Attention

  1.1.2 Business Decisions This Report Supports

 1.2 Scope

 1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Product

  2.3.2 Market Size By Modality

  2.3.3 Market Size By Therapeutic Area

  2.3.4 Market Size By End User

  2.3.5 Market Size By Trial Phase

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Imaging Hardware, Image Analysis Software, Cloud Storage & Reader Expertise Suppliers

  3.4.2 Imaging Core Laboratories & Clinical Trial Imaging Software Providers

  3.4.3 Contract Research Organizations, Imaging Sites & Technology Integrators

  3.4.4 Pharmaceutical, Biotechnology and Medical Device Sponsors

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Clinical Trial Activity Indicators

  4.1.1 Imaging-Dependent Trial Starts

  4.1.2 Oncology, Neurology and Cardiovascular Trial Volumes

  4.1.3 Trial Counts by Phase

  4.1.4 Pharmaceutical and Biotechnology R&D Spending

 4.2 Imaging Service & Software Metrics

  4.2.1 Core Laboratory Image Read Volumes

  4.2.2 Imaging Endpoint and Quality Control Workload

  4.2.3 Modality Mix across CT, MRI, PET, Ultrasound and X-Ray

  4.2.4 Imaging Software Platform Utilization

 4.3 Technology & Analytics Trends

  4.3.1 Artificial Intelligence in Image Analysis

  4.3.2 Quantitative Imaging Biomarker Adoption

  4.3.3 Cloud-Based Image Transfer and Review

  4.3.4 Standardized Imaging Acquisition Protocols

 4.4 Regulatory & Quality Environment

  4.4.1 Regulatory Guidance on Imaging Endpoints

  4.4.2 Good Clinical Practice and Data Integrity Requirements

  4.4.3 Reader Qualification and Variability Controls

  4.4.4 Patient Data Privacy Requirements

 4.5 Outsourcing, Pricing & Competitive Environment

  4.5.1 Sponsor and Contract Research Organization Outsourcing Mix

  4.5.2 Per-Scan and Per-Study Pricing Models

  4.5.3 Provider Acquisitions and Partnerships

  4.5.4 Geographic Expansion of Imaging Networks

5. Clinical Trial Imaging Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)

 5.1 Introduction

 5.2 Services

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Software

6. Clinical Trial Imaging Market Segmental Analysis & Forecast, By Modality, 2022–2035, Value (USD Billion)

 6.1 Introduction

 6.2 Computed Tomography

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Magnetic Resonance Imaging

 6.4 Positron Emission Tomography

 6.5 Ultrasound

 6.6 X-Ray

 6.7 Others

7. Clinical Trial Imaging Market Segmental Analysis & Forecast, By Therapeutic Area, 2022–2035, Value (USD Billion)

 7.1 Introduction

 7.2 Oncology

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Neurology

 7.4 Cardiovascular

 7.5 Others

8. Clinical Trial Imaging Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

 8.1 Introduction

 8.2 Pharmaceutical and Biotechnology Companies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Contract Research Organizations

 8.4 Medical Device Companies

 8.5 Others

9. Clinical Trial Imaging Market Segmental Analysis & Forecast, By Trial Phase, 2022–2035, Value (USD Billion)

 9.1 Introduction

 9.2 Phase I

  9.2.1 Key Trends

  9.2.2 Market Size & Forecast, 2022–2035

 9.3 Phase II

 9.4 Phase III

 9.5 Phase IV

10. Clinical Trial Imaging Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 10.1 Introduction

 10.2 North America

  10.2.1 Key Trends

  10.2.2 Clinical Trial Imaging Market Size & Forecast, By Product, 2022–2035

  10.2.3 Clinical Trial Imaging Market Size & Forecast, By Modality, 2022–2035

  10.2.4 Clinical Trial Imaging Market Size & Forecast, By Therapeutic Area, 2022–2035

  10.2.5 Clinical Trial Imaging Market Size & Forecast, By End User, 2022–2035

  10.2.6 Clinical Trial Imaging Market Size & Forecast, By Trial Phase, 2022–2035

  10.2.7 Clinical Trial Imaging Market Size & Forecast, By Country, 2022–2035

   10.2.7.1 USA

   10.2.7.2 Canada

 10.3 Europe

  10.3.1 Key Trends

  10.3.2 Clinical Trial Imaging Market Size & Forecast, By Product, 2022–2035

  10.3.3 Clinical Trial Imaging Market Size & Forecast, By Modality, 2022–2035

  10.3.4 Clinical Trial Imaging Market Size & Forecast, By Therapeutic Area, 2022–2035

  10.3.5 Clinical Trial Imaging Market Size & Forecast, By End User, 2022–2035

  10.3.6 Clinical Trial Imaging Market Size & Forecast, By Trial Phase, 2022–2035

  10.3.7 Clinical Trial Imaging Market Size & Forecast, By Country, 2022–2035

   10.3.7.1 Germany

   10.3.7.2 UK

   10.3.7.3 France

   10.3.7.4 Italy

   10.3.7.5 Spain

   10.3.7.6 Russia

   10.3.7.7 Poland

   10.3.7.8 Rest of Europe

 10.4 Asia-Pacific

  10.4.1 Key Trends

  10.4.2 Clinical Trial Imaging Market Size & Forecast, By Product, 2022–2035

  10.4.3 Clinical Trial Imaging Market Size & Forecast, By Modality, 2022–2035

  10.4.4 Clinical Trial Imaging Market Size & Forecast, By Therapeutic Area, 2022–2035

  10.4.5 Clinical Trial Imaging Market Size & Forecast, By End User, 2022–2035

  10.4.6 Clinical Trial Imaging Market Size & Forecast, By Trial Phase, 2022–2035

  10.4.7 Clinical Trial Imaging Market Size & Forecast, By Country, 2022–2035

   10.4.7.1 China

   10.4.7.2 India

   10.4.7.3 Japan

   10.4.7.4 South Korea

   10.4.7.5 Australia

   10.4.7.6 ASEAN Countries

   10.4.7.7 Rest of Asia-Pacific

 10.5 Latin America

  10.5.1 Key Trends

  10.5.2 Clinical Trial Imaging Market Size & Forecast, By Product, 2022–2035

  10.5.3 Clinical Trial Imaging Market Size & Forecast, By Modality, 2022–2035

  10.5.4 Clinical Trial Imaging Market Size & Forecast, By Therapeutic Area, 2022–2035

  10.5.5 Clinical Trial Imaging Market Size & Forecast, By End User, 2022–2035

  10.5.6 Clinical Trial Imaging Market Size & Forecast, By Trial Phase, 2022–2035

  10.5.7 Clinical Trial Imaging Market Size & Forecast, By Country, 2022–2035

   10.5.7.1 Brazil

   10.5.7.2 Argentina

   10.5.7.3 Mexico

   10.5.7.4 Colombia

   10.5.7.5 Rest of Latin America

 10.6 Middle East & Africa

  10.6.1 Key Trends

  10.6.2 Clinical Trial Imaging Market Size & Forecast, By Product, 2022–2035

  10.6.3 Clinical Trial Imaging Market Size & Forecast, By Modality, 2022–2035

  10.6.4 Clinical Trial Imaging Market Size & Forecast, By Therapeutic Area, 2022–2035

  10.6.5 Clinical Trial Imaging Market Size & Forecast, By End User, 2022–2035

  10.6.6 Clinical Trial Imaging Market Size & Forecast, By Trial Phase, 2022–2035

  10.6.7 Clinical Trial Imaging Market Size & Forecast, By Country, 2022–2035

   10.6.7.1 UAE

   10.6.7.2 Saudi Arabia

   10.6.7.3 Qatar

   10.6.7.4 South Africa

   10.6.7.5 Rest of Middle East & Africa

11. Competitive Landscape

 11.1 Key Players' Positioning

 11.2 Competitive Developments

  11.2.1 Year-Wise Strategies & Development, 2022–2026

 11.3 Market Share Analysis, 2025

 11.4 Product/Service & Application Benchmarking

  11.4.1 Product/Service Specifications & Features By Key Players

  11.4.2 Product/Service Heatmap By Key Players

  11.4.3 Application Heatmap By Key Players

 11.5 Industry Start-Up & Innovation Landscape

 11.6 Key Company Profiles

  11.6.1 Clario Holdings, Inc. (Thermo Fisher Scientific)

   11.6.1.1 Company Overview & Snapshot

   11.6.1.2 Product/Service Portfolio

   11.6.1.3 Key Company Financials

   11.6.1.4 Geographical Presence

   11.6.1.5 SWOT Analysis

  11.6.2 Calyx (Perceptive Imaging)

  11.6.3 ICON plc

  11.6.4 Medpace, Inc.

  11.6.5 Imaging Endpoints

  11.6.6 Median Technologies

  11.6.7 WCG Intrinsic Imaging, LLC

  11.6.8 Image Analysis Group

  11.6.9 Medidata Solutions, Inc. (Dassault Systèmes)

  11.6.10 Perspectum Limited

  11.6.11 Flywheel

  11.6.12 Altis Labs

  11.6.13 Biotrial

  11.6.14 Banook Group (Keosys)

  11.6.15 QMENTA

  11.6.16 Medical Metrics, Inc.

  11.6.17 Brainomix Limited

  11.6.18 Quibim

  11.6.19 Invicro, LLC (Konica Minolta)

12. Analyst Recommendations

 12.1 SNS Insider Opportunity Map

 12.2 Industry Low-Hanging Fruit Assessment

 12.3 Market Entry & Growth Strategy

 12.4 Analyst Viewpoint & Suggestions On Market Growth

13. Assumptions

14. Disclaimer

15. Appendix

 15.1 List Of Tables

 15.2 List Of Figures